BFC Planning’s Lantern Pharma LTRN Stock Holding History
Bought
Maintained
Sold
Other funds holding LTRN
CM
BFC Planning's LTRN Position: Q3 2026 in Review
BFC Planning increased its Lantern Pharma (LTRN) stake by 15% in Q3 2026, buying an estimated $1.2K and bringing the position to 3,760 shares worth $3.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2795.
BFC Planning first reported a position in LTRN in Q3 2024 and has held it in 9 quarters since. The position peaked at $13.6K in Q2 2026. 36 funds tracked by Wall St. Rank hold LTRN as of Q3 2026.
- BFC Planning held 3,760 shares of Lantern Pharma worth $3.8K as of Q3 2026.
- BFC Planning bought 500 Lantern Pharma shares in Q3 2026, an estimated $1.2K.
- Lantern Pharma made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2795 holding.
- BFC Planning first reported a position in Lantern Pharma in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Lantern Pharma position peaked at $13.6K in Q2 2026.
- 36 funds tracked by Wall St. Rank held Lantern Pharma as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.